CRC patients showed significantly higher levels of glucose, albumin, transferrin, and IL-6, and lower total cholesterol, HDL-cholesterol, LDL-cholesterol, ferritin, iron, and transferrin saturation index than the control group. The gene discussed is IL6; the disease is colorectal carcinoma.